Clinical trials
Phase 1/2 Myositis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Not yet recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University Third Hospital | 2 |
| Essen Biotech | 1 |
| Fate Therapeutics | 1 |
| Myeloid Therapeutics | 1 |
| Nkarta, Inc. | 1 |
| Pfizer | 1 |
| Tianjin Medical University General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myositis | 8 |
| Scleroderma, Systemic | 7 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 5 |
| Lupus Erythematosus, Systemic | 4 |
| Arthritis, Rheumatoid | 3 |
| Sjogren's Syndrome | 3 |
| Autoimmune Diseases | 2 |
| Antiphospholipid Syndrome | 1 |
| Dermatomyositis | 1 |
| Granulomatosis with Polyangiitis | 1 |
Trials
Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.